Phase 2 study of ATRA and arsenic trioxide for acute promyelocytic leukemia
Phase 2
- Conditions
- acute promyelocytic leukemia
- Registration Number
- JPRN-UMIN000012004
- Lead Sponsor
- Department of Hematology, Hiroshima University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1. Severe co-morbidity 2. Pregnant and/or lactating woman 3. Patients who have a difficulty to enter the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method